ResearcherPurdue University West LafayetteActive in the last 2 years
Sae Rome Choi
Matched on ORCID iD 0000-0003-0975-0345; OpenAlex author ID A5088865889. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2025: 1 paper · 2026: 2 papers
Papers 3
- Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.09.024↗
- Extravascular coagulation stabilizes pro-fibrotic stromal states via tumor-intrinsic PAR1 signaling in pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.06.25.734662↗
- DNA Origami-Cyanine Nanocomplex for Precision Imaging of KRAS-Mutant Pancreatic Cancer Cells. Co-author DOI 10.1002/advs.202410278↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hye‐ran Moon · 2 shared papers, 2025–2026 · strength 0.52
- Bumsoo Han · 2 shared papers, 2025–2026 · strength 0.52
- Melissa L. Fishel · 2 shared papers, 2026 · strength 0.47
- Paper Extravascular coagulation stabilizes pro-fibrotic stromal states via tumor-intrinsic PAR1 signaling in pancreatic ducta… DOI 10.64898/2026.06.25.734662↗
- Paper Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.09.024↗
- Matthew J. Flick · 2 shared papers, 2026 · strength 0.47
- Paper Extravascular coagulation stabilizes pro-fibrotic stromal states via tumor-intrinsic PAR1 signaling in pancreatic ducta… DOI 10.64898/2026.06.25.734662↗
- Paper Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.09.024↗
- Claudius H. Conrad · 1 shared paper, 2026 · strength 0.25
- Alisa S. Wolberg · 1 shared paper, 2026 · strength 0.22
- Nayela N. Chowdhury · 1 shared paper, 2026 · strength 0.22
- Silpa Gampala · 1 shared paper, 2026 · strength 0.22
- Wei Ping Jia · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.